Concurrent To Twill Acquisition Deal, Dariohealth Priced $22.4M Equity Financing
Author: Benzinga Newsdesk | February 21, 2024 07:05am
Dario priced a $22.4 million private placement of convertible preferred stock, priced at the market under Nasdaq rules, with participation from investors from both companies. Pursuant to the terms of private placement, Dario agreed to issue shares of newly designated convertible preferred stock (the "Preferred Stock"). Each share of Preferred Stock will be sold at $1,000 per share, with conversion prices of $2.02 and $2.14, raising gross proceeds of $22.4 million
Posted In: DRIO